Thread by @MSF_access

THREAD: During this pandemic, treatment providers and governments have faced shortages of #COVID19 drugs, test reagents, masks, and ventilator valves caused by corporations controlling supply using patents, trade secrets or other IP.

We compiled examples of such shortages⬇️

Example 1- Impact of intellectual property barriers on #COVID19 drugs.

#COVIDshortages
#WhyWeNeedIPWaiver

Example 2- Impact of intellectual property barriers on future #COVID19 #vaccines.

#COVIDshortages
#WhyWeNeedIPWaiver

Example 3- Impact of intellectual property barriers on #COVID19 tests.

#COVIDshortages
#WhyWeNeedIPWaiver

Example 4 - Impact of intellectual property barriers on #COVID19 ventilator valves.

#COVIDshortages
#WhyWeNeedIPWaiver

Example 5 - Impact of intellectual property barriers on #COVID19 N95 respirators (masks).

#COVIDshortages
#WhyWeNeedIPWaiver

Example 6- Impact of intellectual property barriers on #COVID19 testing kit reagents.

#COVIDshortages
#WhyWeNeedIPWaiver

If the waiver proposal by 🇮🇳 🇿🇦 is approved by @WTO, it will support uninterrupted scale-up of production and supply of medical tools to collectively address the global challenge facing all countries.

Read more ⬇️ #WhyWeNeedIPWaiver

bit.ly/3nLAzCC